Juvaris BioTherapeutics Inc., a Pleasanton, Calif.-based developer of vaccines for cancer and infectious diseases, has raised $25 million in the first close of a Series B round.
55594
Juvaris BioTherapeutics raises $25 million
14205
BiteHunter secures $250,000 in seed funding
38012
Bill Gates pledges $US10b for vaccines
157140
Virool raises $6.6 million in seed round
25315
Consert raises $7 million in venture capital
162625
Gates Foundation pledges $255 million to fight polio
88480
Mayo Clinic partnership to advance personalized medicine
158277
MicroPhage raises $11 million
145489
Kaman files statement to raise up to $200 million
165569
Miller shoots to cure Type 1 diabetes
89856
Plastic antibodies may fight a wide range of human diseases
135657
Pharmaceutical product development raises dividend 20 percent
76941
Cruz raises $1.3 million
5481
Regions achieves $25.1 billion in
93478
Electric car maker CODA raises $25 million
6195
Gift for Life raises $225,000
54743
US Oncology unveils new brand campaign